BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8645080)

  • 1. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment.
    Takami H; Ozaki O; Ito K
    Arch Surg; 1996 Jun; 131(6):676. PubMed ID: 8645080
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial nonmedullary thyroid carcinoma.
    Malchoff CD; Malchoff DM
    Semin Surg Oncol; 1999; 16(1):16-8. PubMed ID: 9890735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is familial nonmedullary thyroid carcinoma more aggressive than sporadic nonmedullary thyroid carcinoma?
    Malchoff CD; McDonald TJ
    Thyroid; 2014 Apr; 24(4):782-3. PubMed ID: 24494807
    [No Abstract]   [Full Text] [Related]  

  • 4. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
    Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
    Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in differentiated thyroid gland carcinoma].
    Fonseca E; Soares P; Rossi S; Sobrinho-Simões M
    Pathologe; 1997 Jul; 18(4):275-85. PubMed ID: 9380603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 7. Poorly differentiated carcinoma of the thyroid: an aggressive type of tumour arising from thyroid follicular epithelium.
    Sakamoto A
    Curr Top Pathol; 1997; 91():45-50. PubMed ID: 9018915
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence is not sufficient to recommend a more aggressive approach to familial nonmedullary thyroid cancer.
    Benbassat C
    Thyroid; 2014 Apr; 24(4):781-2. PubMed ID: 24295148
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of YAP1 in aggressive thyroid cancer.
    Celano M; Mignogna C; Rosignolo F; Sponziello M; Iannone M; Lepore SM; Lombardo GE; Maggisano V; Verrienti A; Bulotta S; Durante C; Di Loreto C; Damante G; Russo D
    Endocrine; 2018 Jan; 59(1):209-212. PubMed ID: 28120182
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of MicroRNAs in Thyroid Carcinoma.
    Zhu G; Xie L; Miller D
    Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressiveness in familial nonmedullary thyroid carcinoma--the controversy continues.
    Mazeh H; Sippel RS
    Thyroid; 2014 Apr; 24(4):783-4. PubMed ID: 24660808
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial nonmedullary thyroid carcinoma.
    Mazeh H; Sippel RS
    Thyroid; 2013 Sep; 23(9):1049-56. PubMed ID: 23734600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).
    Lewinski A; Ferenc T; Sporny S; Jarzab B
    Endocr Regul; 2000 Jun; 34(2):99-113. PubMed ID: 10991553
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial nonmedullary thyroid neoplasia.
    Rubén Harach H
    Endocr Pathol; 2001; 12(2):97-112. PubMed ID: 11579685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial nonmedullary thyroid cancer].
    Sugino K; Mimura T; Ito K; Ito K
    Nihon Rinsho; 2000 Jul; 58(7):1519-22. PubMed ID: 10921335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
    Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
    Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of familial nonmedullary thyroid cancer in a large case series.
    Zivaljevic V; Paunovic I; Diklic A; Krgovic K; Kalezic N; Kazic M; Tatic S; Savic D; Stojanovic D; Perunovic R
    Acta Chir Belg; 2008; 108(3):328-32. PubMed ID: 18710108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: synchronous occurrence of anaplastic, follicular, and papillary carcinoma with follicular adenoma in thyroid gland.
    Wasim NA; Hati GC; Guha D; Bhattacharya S
    Indian J Pathol Microbiol; 2011; 54(2):434-5. PubMed ID: 21623130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.